Business Context and Reporting Period
This Form 8-K Current Report was filed by Henry Schein, Inc. on December 12, 2023, with the report date reflecting events occurring on December 12 and December 13, 2023. The filing addresses corporate governance changes and amendments to executive compensation plans.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on non-financial operational and governance matters.
Material Changes
- Board Expansion: The Board of Directors increased its size to fifteen members.
- New Director Appointment: Carole T. Faig was appointed as a new independent director, effective immediately on December 13, 2023.
- Executive Plan Amendment: Amendment Number Four to the Supplemental Executive Retirement Plan was approved, effective January 1, 2024.
Guidance, Outlook, and Management Commentary
Director Background: Ms. Faig brings 38 years of experience from Ernst & Young LLP (EY), where she served as U.S. Health Leader and West Region Health and Life Sciences Leader prior to her retirement in July 2021. Her appointment was recommended by the Nominating and Governance Committee.
Plan Amendment Details: The amendment to the Supplemental Executive Retirement Plan permits joint ventures and other entities owned 50% or more by the Company or its controlled group members to become participating employers, subject to Company approval.
Risks and Contingencies: No specific risks, contingencies, or unusual items were disclosed in this filing.
Investor Verification Checklist
- Verify the full text of Exhibit 10.1 for complete terms of the Supplemental Executive Retirement Plan amendment.
- Review Exhibit 99.1 (Press Release dated December 18, 2023) for additional details on Ms. Faig's appointment.
- Confirm the effective date of the plan amendment is January 1, 2024.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.